Literature DB >> 19125701

Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer.

Vesna Hadziavdić1, Nada Pavlović-Calić, Izet Eminović.   

Abstract

Considering its frequency, high mortality rate as well as many etiological mysteries colorectal cancer is a challenge to contemporary science. In our study we analyzed RER + and RER--phenotypes and their relations with clinical-pathological characteristics of sporadic colorectal cancers. We also analyzed genetic alterations of tumor suppressor genes as well as their relation with microsatellite instability. The study was based on 54 tumor samples and 54 samples of the surrounding healthy tissue of patients with colorectal cancer. According to Amsterdam Criteria and Bethesda Criteria 35/54 or 64,81% belonged in the group of sporadic colorectal cancer. Mononucleotide marker Bat 25 showed instability in 48,57%; Bat 26 in 45,71% and Bat 40 in 29/35 82,86% of tumor samples. Considering dinucleotide markers, TP 53 showed instability in 54,29% and DS123 in 37,14% of tumor samples. Genetic alterations in tumor suppressor genes were found in tumor tissue: NM 23 in 54,29% samples, p53 in 51,43%, APC in 51,43%, DCC2 in 34,29%, RB1 in 22, 86% and DCC 1 in 28,57%. Our studies confirmed that genetic instability had an important role in the development of tumor type. Our results showed that mononucleotide marker Bat 40 might be used for an easy and fast screening procedure in Bosnian population, because it exhibited high percent of microsatellite instability and was in relation with RER+ phenotype. This investigation showed that different genetic alterations may occur during cancer development in each individual patient's tumor. These changes result in MMR inactivation, which causes RER+ phenotype. Our results suggest a connection between alteration in some tumor suppressor genes and MSI phenotype of sporadic colorectal cancer in Bosnian population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19125701      PMCID: PMC5677274          DOI: 10.17305/bjbms.2008.2883

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  41 in total

Review 1.  Are there several types of colorectal carcinomas? Correlations with genetic data.

Authors:  L Martin; M Assem; F Piard
Journal:  Eur J Cancer Prev       Date:  1999-12       Impact factor: 2.497

2.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

Authors:  Y Akiyama; H Sato; T Yamada; H Nagasaki; A Tsuchiya; R Abe; Y Yuasa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

3.  Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer.

Authors:  M J Massa; P Iniesta; R González-Quevedo; C de Juan; T Caldés; A Sánchez-Pernaute; J Cerdán; A J Torres; J L Balibrea; M Benito
Journal:  Eur J Cancer       Date:  1999-11       Impact factor: 9.162

4.  Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.

Authors:  R A Lothe; T Fossli; H E Danielsen; A E Stenwig; J M Nesland; B Gallie; A L Børresen
Journal:  J Natl Cancer Inst       Date:  1992-07-15       Impact factor: 13.506

5.  BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.

Authors:  J M Hoang; P H Cottu; B Thuille; R J Salmon; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

6.  Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology.

Authors:  R Chetty; R Naidoo; J Schneider
Journal:  Mol Pathol       Date:  1998-02

7.  Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.

Authors:  U Schiemann; Y Müller-Koch; M Gross; J Daum; P Lohse; G Baretton; M Muders; T Mussack; R Kopp; E Holinski-Feder
Journal:  Digestion       Date:  2004-04-28       Impact factor: 3.216

8.  Incidence of DNA replication errors in patients with multiple primary cancers.

Authors:  S R Brown; P J Finan; N R Hall; D T Bishop
Journal:  Dis Colon Rectum       Date:  1998-06       Impact factor: 4.585

9.  Loss of heterozygosity detected in formalin-fixed, paraffin-embedded tissue of colorectal carcinoma using a microsatellite located within the deleted in colorectal carcinoma gene.

Authors:  T H Huang; J T Quesenberry; M B Martin; T S Loy; A A Diaz-Arias
Journal:  Diagn Mol Pathol       Date:  1993-06

10.  Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

Authors:  W M Grady; A Rajput; L Myeroff; D F Liu; K Kwon; J Willis; S Markowitz
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

View more
  2 in total

1.  Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.

Authors:  Jinjin Zou; Hesan Luo; Qin Zeng; Zhongyi Dong; Dehua Wu; Li Liu
Journal:  J Transl Med       Date:  2011-06-25       Impact factor: 5.531

2.  Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review).

Authors:  Gloria M Calaf; Tammy C Bleak; Debasish Roy
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.